VIEW FULL EVENT VIDEO
Please view presentation clips in the Agenda below
FACULTY
Jeffrey Rothstein, MD, PhD
The John W. Griffin Director, Brain Science Institute
Professor of Neurology and Neuroscience
Director, Robert Packard Centre for ALS Research
Johns Hopkins University, School of Medicine
Orla Hardiman, BSc, MB, BCh, BAO, MD, FRCPI, FAAN
Academic Unit of Neurology, Professor at Trinity College Dublin
National Clinical Lead Neurology, Trinity Biomedical Sciences Institute
Jeremy M. Shefner, MD, PhD
Chief Medical Officer for Clinical Research
Barrow Neurological Institute
PROGRAM AGENDA
1:30 PM – 1:32 PM
1:32 PM – 1:37 PM
1:37 PM – 1:52 PM
1:52 PM – 2:07 PM
2:07 PM – 2:17 PM
Rebuttal: Traditional vs. Nontraditional
Orla Hardiman, MD, FRCPI, FAAN
Jeremy M. Shefner, MD, PhD
PLAY VIDEO2:17 PM – 2:27 PM
2:27 PM – 2:30 PM
SLIDES
Rethinking Trial Design in ALS: What Are the Ideal Inclusion Criteria and Outcome Measures? A Debate
Renowned faculty will review the advantages of traditional and nontraditional outcome measures and eligibility criteria in ALS trial designs